CAS No. |
170212-26-7 |
中文名称 |
N-((2S,3R,E)-3-羟基-1-(((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)十八-4-烯-2-基)-6-((7-硝基苯并[c][1,2,5]氧二唑-4-基)氨基)己酰胺 |
英文名称 |
N-((2S,3R,E)-3-Hydroxy-1-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)octadec-4-en-2-yl)-6-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)hexanamide |
别名 |
C6?NBD-Sphingosine,?beta-D-galactosyl;N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)aMino]hexanoyl]-D-galactosyl-1-1'-sphingosine;N-[6-[(7-NITRO-2-1,3-BENZOXADIAZOL-4-YL)AMINO]HEXANOYL]-D-GALACTOSYL-1-1'-SPHINGOSINE;C6-NBD GALACTOSYL CERAMIDE;C6 NBD Galactosylceramide (d18:1/6:0);Hexanamide, N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-;C6 NBD-Sphingosine, beta-D-galactosylsphingosine;N-(NBD-Aminocaproyl)sphingosine β-D-galactosyl;N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-galactosyl-β1-1'-sphingosine |
标准英文名 |
N-((2S,3R,E)-3-hydroxy-1-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)octadec-4-en-2-yl)-6-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)hexanamide |
分子式 |
C36H59N5O11 |
分子量 |
737.89
|
精确分子量 |
737.42
|
SMILES |
O=C(N[C@@H](CO[C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O)O)[C@H](O)/C=C/CCCCCCCCCCCCC)CCCCCNC2=CC=C([N+]([O-])=O)C3=NON=C32 |
标准SMILES |
CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCNC1=CC=C(C2=NON=C21)[N+]([O-])=O |
用途 |
C6NBD-galactosylceramide serves as a substrate for neutral β-glucocerebrosidase (GCase) and is used to study the intracellular localization and metabolism of galactosylceramide. |
InChIKey |
ZYEQNDHFYIPTAY-LFUFHFQKSA-N |